ID   FOXA2_RAT               Reviewed;         458 AA.
AC   P32182;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   24-JUL-2024, entry version 176.
DE   RecName: Full=Hepatocyte nuclear factor 3-beta;
DE            Short=HNF-3-beta;
DE            Short=HNF-3B;
DE   AltName: Full=Forkhead box protein A2;
GN   Name=Foxa2; Synonyms=Hnf3b, Tcf-3b, Tcf3b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1672118; DOI=10.1101/gad.5.3.416;
RA   Lai E., Prezioso V.R., Tao W.F., Chen W.S., Darnell J.E. Jr.;
RT   "Hepatocyte nuclear factor 3 alpha belongs to a gene family in mammals that
RT   is homologous to the Drosophila homeotic gene fork head.";
RL   Genes Dev. 5:416-427(1991).
RN   [2]
RP   TRANSACTIVATION DOMAIN.
RX   PubMed=1324404; DOI=10.1128/mcb.12.9.3723-3732.1992;
RA   Pani L., Overdier D.G., Porcella A., Qian X., Lai E., Costa R.H.;
RT   "Hepatocyte nuclear factor 3 beta contains two transcriptional activation
RT   domains, one of which is novel and conserved with the Drosophila fork head
RT   protein.";
RL   Mol. Cell. Biol. 12:3723-3732(1992).
RN   [3]
RP   DNA-BINDING CONSENSUS SEQUENCE.
RX   PubMed=8139574; DOI=10.1128/mcb.14.4.2755-2766.1994;
RA   Overdier D.G., Porcella A., Costa R.H.;
RT   "The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead
RT   domain is influenced by amino-acid residues adjacent to the recognition
RT   helix.";
RL   Mol. Cell. Biol. 14:2755-2766(1994).
RN   [4]
RP   TRANSACTIVATION DOMAIN, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND
RP   MUTAGENESIS OF TYR-18.
RX   PubMed=7739897; DOI=10.1093/nar/23.7.1184;
RA   Qian X., Costa R.H.;
RT   "Analysis of hepatocyte nuclear factor-3 beta protein domains required for
RT   transcriptional activation and nuclear targeting.";
RL   Nucleic Acids Res. 23:1184-1191(1995).
RN   [5]
RP   INTERACTION WITH TLE1.
RX   PubMed=10748198; DOI=10.1074/jbc.m910211199;
RA   Wang J.-C., Waltner-Law M., Yamada K., Osawa H., Stifani S., Granner D.K.;
RT   "Transducin-like enhancer of split proteins, the human homologs of
RT   Drosophila groucho, interact with hepatic nuclear factor 3beta.";
RL   J. Biol. Chem. 275:18418-18423(2000).
RN   [6]
RP   FUNCTION.
RX   PubMed=10931833; DOI=10.1074/jbc.m004027200;
RA   Delesque-Touchard N., Park S.H., Waxman D.J.;
RT   "Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene
RT   expression and suppression by growth hormone-activated STAT5b. Proposed
RT   model for female specific expression of CYP2C12 in adult rat liver.";
RL   J. Biol. Chem. 275:34173-34182(2000).
RN   [7]
RP   PHOSPHORYLATION AT THR-156, SUBCELLULAR LOCATION, INTERACTION WITH AKT1,
RP   AND MUTAGENESIS OF ARG-153 AND THR-156.
RX   PubMed=14500912; DOI=10.1073/pnas.1931483100;
RA   Wolfrum C., Besser D., Luca E., Stoffel M.;
RT   "Insulin regulates the activity of forkhead transcription factor Hnf-
RT   3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic
RT   localization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:11624-11629(2003).
RN   [8]
RP   FUNCTION, INTERACTION WITH PRKDC, PHOSPHORYLATION AT SER-212; SER-283;
RP   SER-303; SER-306; SER-307; SER-309; SER-437 AND SER-458, AND MUTAGENESIS OF
RP   THR-280 AND SER-283.
RX   PubMed=19478084; DOI=10.1074/jbc.m109.016295;
RA   Nock A., Ascano J.M., Jones T., Barrero M.J., Sugiyama N., Tomita M.,
RA   Ishihama Y., Malik S.;
RT   "Identification of DNA-dependent protein kinase as a cofactor for the
RT   forkhead transcription factor FoxA2.";
RL   J. Biol. Chem. 284:19915-19926(2009).
RN   [9]
RP   SUBCELLULAR LOCATION, NUCLEAR LOCALIZATION SIGNAL, AND MUTAGENESIS OF
RP   LEU-110; LEU-113 AND THR-156.
RX   PubMed=19589781; DOI=10.1074/jbc.m109.042135;
RA   Howell J.J., Stoffel M.;
RT   "Nuclear export-independent inhibition of Foxa2 by insulin.";
RL   J. Biol. Chem. 284:24816-24824(2009).
CC   -!- FUNCTION: Transcription factor that is involved in embryonic
CC       development, establishment of tissue-specific gene expression and
CC       regulation of gene expression in differentiated tissues. Is thought to
CC       act as a 'pioneer' factor opening the compacted chromatin for other
CC       proteins through interactions with nucleosomal core histones and
CC       thereby replacing linker histones at target enhancer and/or promoter
CC       sites. Binds DNA with the consensus sequence 5'-
CC       [AC]A[AT]T[AG]TT[GT][AG][CT]T[CT]-3' (By similarity). In embryonic
CC       development is required for notochord formation. Involved in the
CC       development of multiple endoderm-derived organ systems such as the
CC       liver, pancreas and lungs; FOXA1 and FOXA2 seem to have at least in
CC       part redundant roles. Originally described as a transcription activator
CC       for a number of liver genes such as AFP, albumin, tyrosine
CC       aminotransferase, PEPCK, etc. Interacts with the cis-acting regulatory
CC       regions of these genes. Involved in glucose homeostasis; regulates the
CC       expression of genes important for glucose sensing in pancreatic beta-
CC       cells and glucose homeostasis (By similarity). Involved in regulation
CC       of fat metabolism. Acts synergistically with ONECUT1 to activate
CC       transcription of female-specific CYP2C12; the function is inhibited by
CC       growth hormone-activated STAT5B. Acts synergistically with HNF4A to
CC       activate transcription of APOA1. {ECO:0000250,
CC       ECO:0000269|PubMed:10931833, ECO:0000269|PubMed:19478084}.
CC   -!- SUBUNIT: Binds DNA as a monomer. Binds TLE1 (PubMed:10748198).
CC       Interacts with FOXA1 and FOXA3 (By similarity). Interacts with PRKDC
CC       (PubMed:19478084). Interacts with AKT1 (PubMed:14500912). Interacts
CC       with TET1; this interaction may recruit TET1 to specific genomic loci
CC       to mediate their demethylation (By similarity).
CC       {ECO:0000250|UniProtKB:Q9Y261, ECO:0000269|PubMed:10748198,
CC       ECO:0000269|PubMed:14500912, ECO:0000269|PubMed:19478084}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Shuttles between the
CC       nucleus and cytoplasm in a CRM1-dependent manner; in response to
CC       insulin signaling via AKT1 is exported from the nucleus.
CC   -!- TISSUE SPECIFICITY: Liver.
CC   -!- PTM: Phosphorylation on Thr-156 abolishes binding to target promoters
CC       and subsequent transcription activation upon insulin stimulation.
CC       {ECO:0000269|PubMed:14500912, ECO:0000269|PubMed:19478084,
CC       ECO:0000269|PubMed:7739897}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L09647; AAA41338.1; -; mRNA.
DR   PIR; B39533; B39533.
DR   RefSeq; NP_036875.1; NM_012743.1.
DR   AlphaFoldDB; P32182; -.
DR   SMR; P32182; -.
DR   IntAct; P32182; 1.
DR   STRING; 10116.ENSRNOP00000017742; -.
DR   iPTMnet; P32182; -.
DR   PhosphoSitePlus; P32182; -.
DR   PaxDb; 10116-ENSRNOP00000017742; -.
DR   GeneID; 25099; -.
DR   KEGG; rno:25099; -.
DR   AGR; RGD:2808; -.
DR   CTD; 3170; -.
DR   RGD; 2808; Foxa2.
DR   eggNOG; KOG3563; Eukaryota.
DR   InParanoid; P32182; -.
DR   OrthoDB; 5385885at2759; -.
DR   PhylomeDB; P32182; -.
DR   PRO; PR:P32182; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0019900; F:kinase binding; IPI:RGD.
DR   GO; GO:0003676; F:nucleic acid binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:InterPro.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0046332; F:SMAD binding; IDA:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0008344; P:adult locomotory behavior; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048646; P:anatomical structure formation involved in morphogenesis; ISO:RGD.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; ISO:RGD.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; ISO:RGD.
DR   GO; GO:0048468; P:cell development; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0021533; P:cell differentiation in hindbrain; ISO:RGD.
DR   GO; GO:0001708; P:cell fate specification; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0071276; P:cellular response to cadmium ion; ISO:RGD.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0061448; P:connective tissue development; ISO:RGD.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0021904; P:dorsal/ventral neural tube patterning; ISO:RGD.
DR   GO; GO:0009953; P:dorsal/ventral pattern formation; ISO:RGD.
DR   GO; GO:0001705; P:ectoderm formation; ISO:RGD.
DR   GO; GO:0031018; P:endocrine pancreas development; ISO:RGD.
DR   GO; GO:0060441; P:epithelial tube branching involved in lung morphogenesis; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0010255; P:glucose mediated signaling pathway; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0060487; P:lung epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0048382; P:mesendoderm development; ISO:RGD.
DR   GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; ISO:RGD.
DR   GO; GO:0061987; P:negative regulation of transcription from RNA polymerase II promoter by glucose; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0048665; P:neuron fate specification; ISO:RGD.
DR   GO; GO:0007219; P:Notch signaling pathway; ISO:RGD.
DR   GO; GO:0007389; P:pattern specification process; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:1904340; P:positive regulation of dopaminergic neuron differentiation; ISO:RGD.
DR   GO; GO:0040019; P:positive regulation of embryonic development; ISS:UniProtKB.
DR   GO; GO:2000543; P:positive regulation of gastrulation; ISS:UniProtKB.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISO:RGD.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0045945; P:positive regulation of transcription by RNA polymerase III; ISO:RGD.
DR   GO; GO:0000432; P:positive regulation of transcription from RNA polymerase II promoter by glucose; ISO:RGD.
DR   GO; GO:0090009; P:primitive streak formation; ISS:UniProtKB.
DR   GO; GO:0030193; P:regulation of blood coagulation; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; ISO:RGD.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; ISO:RGD.
DR   GO; GO:0019218; P:regulation of steroid metabolic process; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   GO; GO:0023019; P:signal transduction involved in regulation of gene expression; ISO:RGD.
DR   GO; GO:0007224; P:smoothened signaling pathway; ISO:RGD.
DR   GO; GO:0032525; P:somite rostral/caudal axis specification; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   CDD; cd20039; FH_FOXA2; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR013638; Fork-head_N.
DR   InterPro; IPR001766; Fork_head_dom.
DR   InterPro; IPR018533; Forkhead_box_C.
DR   InterPro; IPR050211; FOX_domain-containing.
DR   InterPro; IPR018122; TF_fork_head_CS_1.
DR   InterPro; IPR030456; TF_fork_head_CS_2.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR11829; FORKHEAD BOX PROTEIN; 1.
DR   PANTHER; PTHR11829:SF167; HEPATOCYTE NUCLEAR FACTOR 3-BETA; 1.
DR   Pfam; PF00250; Forkhead; 1.
DR   Pfam; PF08430; Forkhead_N; 1.
DR   Pfam; PF09354; HNF_C; 1.
DR   PRINTS; PR00053; FORKHEAD.
DR   SMART; SM00339; FH; 1.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.
DR   PROSITE; PS00657; FORK_HEAD_1; 1.
DR   PROSITE; PS00658; FORK_HEAD_2; 1.
DR   PROSITE; PS50039; FORK_HEAD_3; 1.
PE   1: Evidence at protein level;
KW   Activator; Chromatin regulator; Cytoplasm; Developmental protein;
KW   DNA-binding; Nucleus; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..458
FT                   /note="Hepatocyte nuclear factor 3-beta"
FT                   /id="PRO_0000091797"
FT   DNA_BIND        159..252
FT                   /note="Fork-head"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00089"
FT   REGION          14..93
FT                   /note="Transactivation domain 1"
FT   REGION          286..365
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          361..458
FT                   /note="Transactivation domain 2"
FT   MOTIF           106..113
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:19589781"
FT   COMPBIAS        286..310
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         156
FT                   /note="Phosphothreonine; by PKB/AKT1"
FT                   /evidence="ECO:0000269|PubMed:14500912"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19478084"
FT   MOD_RES         283
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19478084"
FT   MOD_RES         301
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P35583"
FT   MOD_RES         303
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19478084"
FT   MOD_RES         306
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19478084"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19478084"
FT   MOD_RES         309
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19478084"
FT   MOD_RES         437
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19478084"
FT   MOD_RES         458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:19478084"
FT   MUTAGEN         18
FT                   /note="Y->P: Reduces transcriptional activation."
FT                   /evidence="ECO:0000269|PubMed:7739897"
FT   MUTAGEN         110
FT                   /note="L->A: Inhibits nuclear export; when associated with
FT                   A-113."
FT                   /evidence="ECO:0000269|PubMed:19589781"
FT   MUTAGEN         113
FT                   /note="L->A: Inhibits nuclear export; when associated with
FT                   A-110."
FT                   /evidence="ECO:0000269|PubMed:19589781"
FT   MUTAGEN         153
FT                   /note="R->K: Abolishes interaction with AKT1."
FT                   /evidence="ECO:0000269|PubMed:14500912"
FT   MUTAGEN         156
FT                   /note="T->A: Constitutive active. Abolishes phosphorylation
FT                   by PKB/AKT1; inhibits nuclear export; no effect on DNA
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:14500912,
FT                   ECO:0000269|PubMed:19589781"
FT   MUTAGEN         280
FT                   /note="T->A: Impairs transcriptional activation; when
FT                   associated with A-283."
FT                   /evidence="ECO:0000269|PubMed:19478084"
FT   MUTAGEN         283
FT                   /note="S->A: Abolishes in vitro phosphorylation by PRKDC.
FT                   Impairs transcriptional activation; when associated with A-
FT                   280."
FT                   /evidence="ECO:0000269|PubMed:19478084"
SQ   SEQUENCE   458 AA;  48484 MW;  9FF754142C194055 CRC64;
     MLGAVKMEGH EPSDWSSYYA EPEGYSSVSN MNASLGMNGM NTYMSMSAAA MGSGSGNMSA
     GSMNMSSYVG AGMSPSLAGM SPGAGAMAGM SGSAGAAGVA GMGPHLSPSL SPLGGQAAGA
     MGGLAPYANM NSMSPMYGQA GLSRARDPKT YRRSYTHAKP PYSYISLITM AIQQSPNKML
     TLSEIYQWIM DLFPFYRQNQ QRWQNSIRHS LSFNDFLKVP RAPDKPGKGS FWTLHPDSGN
     MFENGCYLRR QKRFKCENEL ALKEAAGAGS GGGKKTAPGT QASQVQLGEA AGSASETPAG
     TESPHSSASP CQEHKRGGLS ELKGTPASAL SPPEPAPSPG QQQQAAAHLL GPPHHPGLPP
     EAHLKPEHHY AFNHPFSINN LMSSEQQHHH SHHHHQPHKM DLKTYEQVMH YPGGYGSPMP
     GSLAMGPVTN KAGLDASPLA ADTSYYQGVY SRPIMNSS
//
